In the News
CHCWM’s Dr. Yuanbin Chen – Journal of Thoracic Oncology
05/22/2019
CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”. Read the Article Read more »
CHCWM – START Midwest article in Yahoo Finance
05/21/2019
CHC’s START Midwest program is in on another Phase I clinical trial making the news. Read the Article Read more »
CHCWM – Publication in the American Journal of Managed Care
05/20/2019
CHC’s Wendy Koopman (Clinical Director and Nurse Practitioner), for her work on the Evidence Based Oncology – Adverse Event Tracking article, featured in the April 2019 issue of The American Journal of Managed Care. Read the Article Read more »
START Midwest – Publication in the Journal of Clinical Oncology
03/14/2019
CHC’s Dr. Chandana, Dr. Lakhani, and Dr. O’Rourke, in their work with our START Midwest Phase I Clinical trials, are featured in the February 27, 2019 issue of The Journal of Clinical Oncology. Read the Study Read more »
CHCWM Wins 2018 Best and Brightest Companies to Work For in the Nation
12/01/2018
Congratulations to the entire staff here at CHC! Awards like this are only possible because of the amazing people who work here. Your hard work and exceptional effort make this company what it is today! We look forward to bigger Read More »
CHCWM’s Lab & Eve Graham Featured in CAP Today Publication
CHC’s Director of Laboratory Services, Eve Graham, is featured in CAP Today’s Article “Advanced parameters offer faster, surer guidance to cancer care.”
09/18/2017
“The general pattern, Dr. Hirsch-Ginsberg says, is that diagnostic tools often stay investigational for a long time before they’re as widely used as they could be. But she and Dr. Peerschke express confidence in the Sysmex advanced parameters’ robustness and Read More »